Latest Europe News

Imdex Limited reported a stabilisation in global exploration activity after a prolonged downturn, highlighting resilience despite a 19% revenue dip in 3Q25 and outlining a growth strategy focused on technology and integrated solutions.

Unibail-Rodamco-Westfield and Cenomi Centers have entered a decade-long exclusive partnership to bring the Westfield brand to Saudi Arabia’s premier shopping centres, aiming to reshape retail experiences across the Kingdom’s largest cities.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.

Green Critical Minerals has secured a formal sample request from a leading European thermal management provider, marking a significant step in commercialising its VHD Graphite technology across multiple high-demand sectors.

Zoono Group Limited has responded to an ASX price query following unusual trading activity, confirming no undisclosed price-sensitive information exists and linking the movement to ongoing shelf-life extension trials with OSY Group Ltd and multiple international partners.

Corporate Travel Management revises down its FY25 revenue outlook by 4%, citing tariff and economic uncertainties in North America and Asia, while strong client wins bolster confidence for FY26.

Vmoto Limited reported a 16% decline in total unit sales for 1Q25, offset by a strong cash position and strategic investments in e-mobility solutions and production capacity.

Redivium Limited has launched its Trading Division and secured key agreements as it pushes forward with European battery recycling projects, though funding challenges remain.

Clean TeQ Water has landed a A$1.2 million engineering contract to design a DESALX® wastewater treatment plant for Nyrstar's European operations, paving the way for a potential A$9.4 million project stage.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

Dimerix Limited has announced a US licensing transaction for its Phase 3 asset DMX-200 targeting FSGS, alongside progress updates on its clinical trial. The move underscores the company’s push to address a rare kidney disease with no approved therapies.